Remission of collagen-induced arthritis through combination therapy of microfracture and transplantation of thermogel-encapsulated bone marrow mesenchymal stem cells

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Liu, He ^a   Ding, Jianxun ^b   Wang, Jincheng ^a   Wang, Yinan ^c   Yang, Modi ^a   Zhang, Yanbo ^a   Chang, Fei ^a   Chen, Xuesi ^b  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE II ANTIBODY; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTHRITIS; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CD4 CD8 RATIO; CELL ENCAPSULATION; CELL FUNCTION; CELL SPECIFICITY; CHONDROPATHY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CONTROL; DISEASE SEVERITY; DOWN REGULATION; GEL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR DYNAMICS; NONHUMAN; RAT; REMISSION; SYNDROME DELINEATION; THERMOGEL; TISSUE INJURY; ANIMAL; ARTHRITIS, EXPERIMENTAL; ARTICULAR CARTILAGE; CYTOLOGY; DISEASE MODEL; HYPERPLASIA; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; SYNOVIUM;

RATTUS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; CYTOKINES; DISEASE MODELS, ANIMAL; HYPERPLASIA; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; SYNOVIAL MEMBRANE;

EID: 84925013213     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120596     Document Type: Article

References (50)

1. Kyburz D, Finckh A. The importance of early treatment for the prognosis of rheumatoid arthritis. Swiss Med Wkly. 2013;143:w13865. doi: 10.4414/smw.2013.13865 PMID: 24089023
2. Lequerre T, Avenel G, Vittecoq O. Therapeutic update in rheumatoid arthritis. Rev Med Interne. 2013;34:754-762. doi: 10.1016/j.revmed.2013.09.010 PMID: 24200099
3. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73:492-509. doi: 10.1136/annrheumdis-2013-204573 PMID: 24161836
4. Danoff JR, Moss G, Liabaud B, Geller JA. Total knee arthroplasty considerations in rheumatoid arthritis. Autoimmune Dis. 2013;2013:185340. doi: 10.1155/2013/185340 PMID: 24151549
5. Beane OS, Darling EM. Isolation, characterization, and differentiation of stem cells for cartilage regeneration. Ann Biomed Eng. 2012;40:2079-2097. doi: 10.1007/s10439-012-0639-8 PMID: 22907257
6. Liu Z, Wang W, Gao J, Zhou H, Zhang Y. Isolation, culture, and induced multiple differentiation of Mongolian sheep bone marrow-derived mesenchymal stem cells. In Vitro Cell Dev-An. 2014;50:464-474. doi: 10.1007/s11626-013-9725-y PMID: 24399254
7. Chang F, Ishii T, Yanai T, Mishima H, Akaogi H, Ogawa T, et al. Repair of large full-thickness articular cartilage defects by transplantation of autologous uncultured bone-marrow-derived mononuclear cells. J Orthop Res. 2008;26:18-26. PMID: 17724730
8. Endres M, Neumann K, Haupl T, Erggelet C, Ringe J, Sittinger M, et al. Synovial fluid recruits human mesenchymal progenitors from subchondral spongious bone marrow. J Orthop Res. 2007;25:1299-1307. PMID: 17549723
9. Sanchez-Berna I, Santiago-Diaz C, Jimenez-Alonso J. Immunomodulatory properties of stem mesenchymal cells in autoimmune diseases. Med Clin (Barc):2015;144:88-91. doi: 10.1016/j.medcli.2014. 01.014 PMID: 24636281
10. Singer NG, Caplan AI. Mesenchymal Stem Cells: Mechanisms of Inflammation. Annu Rev Pathol-Mech. 2011;6:457-478. doi: 10.1146/annurev-pathol-011110-130230 PMID: 21073342
11. Gonzalez-Rey E, Gonzalez MA, Varela N, O'Valle F, Hernandez-Cortes P, Rico L, et al. Human adiposederived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis. 2010;69:241-248. doi: 10.1136/ard.2008. 101881 PMID: 19124525
12. Tyndall A, Uccelli A. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. Bone Marrow Transpl. 2009;43:821-828.
13. Mohanty ST, Kottam L, Gambardella A, Nicklin MJ, Coulton L, Hughes D, et al. Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis. Arthritis Res Ther. 2010;12:R149. doi: 10.1186/ar3098 PMID: 20649960
14. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev. 2008;129:163-173. doi: 10. 1016/j.mad.2007.12.002 PMID: 18241911
15. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31:890-896. PMID: 14550804
16. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum. 2007;56:1175-1186. PMID: 17393437
17. Mao F, Xu WR, Qian H, Zhu W, Yan YM, Shao QX, et al. Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis. Inflamm Res. 2010;59:219-225. doi: 10.1007/s00011-009-0090-y PMID: 19763787
18. Keerthi N, Chimutengwende-Gordon M, Sanghani A, Khan W. The potential of stem cell therapy for osteoarthritis and rheumatoid arthritis. Curr Stem Cell Res T. 2013;8:444-450. PMID: 24016323
19. Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheumatol. 2009;60:1006-1019.
20. Kehoe O, Cartwright A, Askari A, El Haj AJ, Middleton J. Intra-articular injection of mesenchymal stem cells leads to reduced inflammation and cartilage damage in murine antigen-induced arthritis. J Transl Med. 2014;12:157. doi: 10.1186/1479-5876-12-157 PMID: 24893776
21. Otte P. Basic cell metabolism of articular cartilage. Manometric studies. Z Rheumatol. 1991;50:304-312. PMID: 1776367
22. Teuschl AH, Nurnberger S, Redl H, Nau T. Articular cartilage tissue regeneration-current research strategies and outlook for the future. Eur Surg. 2013;45:142-153.
23. Spiller KL, Maher SA, Lowman AM. Hydrogels for the repair of articular cartilage defects. Tissue Eng Part B-Re. 2011;17:281-299.
24. Tan HP, Marra KG. Injectable, biodegradable hydrogels for tissue engineering applications. Materials. 2010;3:1746-1767.
25. Niranjan R, Koushik C, Saravanan S, Moorthi A, Vairamani M, Selvamurugan N. A novel injectable temperaturesensitive zinc doped chitosan/beta-glycerophosphate hydrogel for bone tissue engineering. Int J Biol Macromol. 2013;54:24-29. doi: 10.1016/j.ijbiomac.2012.11.026 PMID: 23201776
26. Cui H, Liu Y, Cheng Y, Zhang Z, Zhang P, Chen X, et al. In vitro study of electroactive tetraaniline-containing thermosensitive hydrogels for cardiac tissue engineering. Biomacromolecules. 2014;15:1115-1123. doi: 10.1021/bm4018963 PMID: 24597966
27. He CL, Kim SW, Lee DS. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release. 2008;127:189-207. doi: 10.1016/j.jconrel.2008.01.005 PMID: 18321604
28. Yu L, Ding JD. Injectable hydrogels as unique biomedical materials. Chem Soc Rev. 2008;37:1473-1481. doi: 10.1039/b713009k PMID: 18648673
29. Zhang YB, Ding JX, Xu WG, Wu J, Chang F, Zhuang XL, et al. Biodegradable thermogel as culture matrix of bone marrow mesenchymal stem cells for potential cartilage tissue engineering. Chinese J Polym Sci. 2014;32: pp 1590-1601.
30. Ma H, He C, Cheng Y, Li D, Gong Y, Liu J, et al. PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment. Biomaterials. 2014;35:8723-34. doi: 10.1016/j.biomaterials.2014.06.045 PMID: 25017095
31. Liu YY, Mu R, Wang SY, Long L, Liu X, Li R, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther. 2010;12:R210. doi: 10. 1186/ar3187 PMID: 21080925
32. Matheu V, Treschow A, Teige I, Navikas V, Issazadeh-Navikas S. Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice. Resp Res. 2005;6:25.
33. Krenn V, Morawietz L, Haupl T, Neidel J, Petersen I, König A. Grading of chronic synovitis-A histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract. 2002;198:317-325. PMID: 12092767
34. Cake MA, Read RA, Guillou B, Ghosh P. Modification of articular cartilage and subchondral bone pathology in an ovine meniscectomy model of osteoarthritis by avocado and soya unsaponifiables (ASU). Osteoarthr Cartilage. 2000;8:404-411. PMID: 11069724
35. Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, et al. Type-II collagen-induced murine arthritis. 1. Induction and perpetuation of arthritis require synergy between humoral and cell-mediatedimmunity. J Immunol. 1988;140:1477-1484. PMID: 3257978
36. Poulet B, De Souza R, Kent AV, Saxon L, Barker O, Wilson A, et al. Thickening of subchondral bone is regionalised by loading of damaged articular cartilage and contra-lateral changes are linked to gait modification. Osteoarthr Cartilage. 2013;21:S68.
37. Barkholt L, Flory E, Jekerle V, Lucas-Samuel S, Ahnert P, Bisset L, et al. Risk of tumorigenicity in mesenchymal stromal cell-based therapies-bridging scientific observations and regulatory viewpoints. Cytotherapy. 2013;15:753-759. doi: 10.1016/j.jcyt.2013.03.005 PMID: 23602595
38. Granero-Molto F, Weis JA, Miga MI, Landis B, Myers TJ, O'Rear L, et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells. 2009;27:1887-1898. doi: 10.1002/stem.103 PMID: 19544445
39. Aletaha D, Neogi T, Silman AJ. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580-1588. doi: 10.1136/ard.2010.138461 PMID: 20699241
40. De Isla NG, Stoltz JF. In vitro inhibition of IL-1 beta catabolic effects on cartilage: A mechanism involved on diacerein anti-OA properties. Biorheology. 2008;45:433-438. PMID: 18836243
41. Kotake S, Nanke Y. Effect of TNF alpha on osteoblastogenesis from mesenchymal stem cells. Bba-Gen Subjects. 2014;1840:1209-1213. doi: 10.1016/j.bbagen. 2013.12.013 PMID: 24361610
42. Choi JJ, Yoo SA, Park SJ, Kang YJ, Kim WU, Oh IH, et al. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol. 2008;153:269-276. doi: 10.1111/j.1365-2249.2008.03683.x PMID: 18713142
43. Izquierdo E, Canete JD, Celis R, Del Rey MJ, Usategui A, Marsal S, et al. Synovial fibroblast hyperplasia in rheumatoid arthritis clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapy. Arthritis Rheum. 2011;63:2575-2583. doi: 10.1002/art.30433 PMID: 21547893
44. Del Rey MJ, Izquierdo E, Caja S, Usategui A, Santiago B, Galindo M, et al. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1 alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum. 2009;60:2926-2934. doi: 10.1002/art.24844 PMID: 19790065
45. Buckley CD, Filer A, Haworth O, Parsonage G, Salmon M. Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease. Ann Rheum Dis. 2004;63:S92-95.
46. Armaka M, Apostolaki M, Jacques P, Kontoyiannis DL, Elewaut D, Kollias G. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J Exp Med. 2008;205:331-337. doi: 10.1084/jem.20070906 PMID: 18250193
47. Zheng ZH, Li XY, Ding J, Jia JF, Zhu P. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology. 2008;47:22-30. PMID: 18077486
48. Jones S, Horwood N, Cope A, Dazzzi F. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol. 2007;179:2824-2831. PMID: 17709496
49. Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 2005;52:1595-1603. PMID: 15880818
50. Liu Y, Wu JM, Zhu YM, Han JX. Therapeutic application of mesenchymal stem cells in bone and joint diseases. Clin Exp Med. 2014;14:13-24. doi: 10.1007/s10238-012-0218-1 PMID: 23124706